Royalty Pharma plc(RPRX)内部人交易:高管与董事近期交易
过去 18 个月,共有 14 位内部人为 Royalty Pharma plc(RPRX)报告了 134 笔 Form 4 交易(最近一笔 2026-11-18)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-18 | Hite Christopher | EVP & Chairman, Partnering | 卖出 | 100,000 | $6.8M |
| 2026-11-18 | Coyne Terrance P. | EVP & CFO | 卖出 | 135,249 | $9.3M |
| 2026-11-18 | Urist Marshall | EVP, Research & Investments | 卖出 | 23,592 | $1.6M |
| 2026-11-18 | Coyne Terrance P. | EVP & CFO | 卖出 | 14,751 | $1.0M |
| 2026-11-18 | Urist Marshall | EVP, Research & Investments | 卖出 | 1,408 | $98,552 |
| 2026-11-18 | Coyne Terrance P. | EVP & CFO | 卖出 | 90,165 | $6.2M |
| 2026-11-18 | Coyne Terrance P. | EVP & CFO | 卖出 | 9,835 | $671,777 |
| 2026-11-18 | Coyne Terrance P. | EVP & CFO | 卖出 | 7,122 | $490,478 |
| 2026-11-06 | Coyne Terrance P. | EVP & CFO | 买入 | 150,000 | $0 |
| 2026-11-06 | Hite Christopher | EVP & Chairman, Partnering | 买入 | 7,122 | $0 |
| 2026-11-06 | Coyne Terrance P. | EVP & CFO | 买入 | 7,122 | $0 |
| 2026-11-06 | Urist Marshall | EVP, Research & Investments | 买入 | 5,341 | $0 |
| 2026-11-06 | Legorreta Pablo G. | CEO, Chairman of the Board | 买入 | 42,209 | $0 |
| 2026-11-06 | Urist Marshall | EVP, Research & Investments | 买入 | 150,000 | $0 |
| 2026-11-06 | Coyne Terrance P. | EVP & CFO | 买入 | 100,000 | $0 |
| 2026-10-05 | Urist Marshall | EVP, Research & Investments | 卖出 | 4,126 | $235,595 |
| 2026-09-30 | Bassler Bonnie L | 董事 | 买入 | 642 | $37,499 |
| 2026-09-30 | Urist Marshall | EVP, Research & Investments | 卖出 | 4,126 | $238,813 |
| 2026-09-24 | Hite Christopher | EVP & Chairman, Partnering | 卖出 | 96,073 | $5.6M |
| 2026-09-24 | Hite Christopher | EVP & Chairman, Partnering | 卖出 | 3,927 | $231,418 |
| 2026-08-19 | Hite Christopher | EVP & Chairman, Partnering | 卖出 | 100,000 | $6.0M |
| 2026-08-19 | Hite Christopher | EVP & Chairman, Partnering | 卖出 | 16,800 | $0 |
| 2026-08-17 | Coyne Terrance P. | EVP & CFO | 卖出 | 9,230 | $540,786 |
| 2026-08-17 | Coyne Terrance P. | EVP & CFO | 卖出 | 1,772 | $104,796 |
| 2026-08-07 | Coyne Terrance P. | EVP & CFO | 买入 | 11,002 | $0 |
来源:SEC Form 4 申报文件 · 截至 2026-11-18